Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD         Dupixent is indicated for the approximately 300,000 adults in the US with inadequately ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...

giving patients living with this devastating disease the chance to look forward to the potential of improved breathing and a life with fewer exacerbations,” Sanofi CEO Paul Hudson said in a statement.

Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...

Sanofi has claimed FDA approval for its anti-CD38 drug isatuximab as a third-line treatment for multiple myeloma, becoming the first direct rival to Johnson & Johnson’s big-selling Darzalex.

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16,617.05 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

The Democrat faces five criminal charges and could face decades in prison if found guilty. Environmentcategory Hurricane Helene hits Florida as one of the largest storms to strike US 5:03 AM UTC ...

India has signed the Biodiversity Beyond National Jurisdiction (BBNJ) Agreement, or 'High Seas Treaty,' to strengthen its strategic presence beyond its Exclusive Economic Zone. External Affairs ...

Former Canadian politician suspected of working for foreign government: CSIS Former Canadian politician suspected of working for foreign government: CSIS Canada’s intelligence community released ...

ChatGPT vs. Google Gemini: Which Chatbot Wins?